Pharmexcil Web
   
Contact Us Sitemap Feedback Faq's Facebook Twitter
Pharmexcil News
Print E-mail
RX India Pharmexcil Logo RX India
PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA
(Set up by Ministry of Commerce & Industry, Govt. of India)
 
Ref: PXL/H.O./CIR-070/2012-13 Date: 05.09.2012
Important to Exporters of APIs to EU -  the new directive of EU

To
All the Members of Council,

Dear Sir / Madam,

Sub: “Interactive Meeting with European Commission” on 13th September 2012 at 6:00 pm at Hotel Taj Deccan, Hyderabad.

As members are aware about the recent developments in the European Union’s Directive on “New Rules on Importing Active Pharmaceutical Ingredients into the EU”. The European Union (EU) has reformed the rules for importing into the EU active substances for medicinal products for human use.

This new Directive is coming into effect from 2nd July 2013, stating that all imported active substances should be manufactured in compliance with standards of good manufacturing practices (GMP) at least equivalent to the GMP of the EU. The manufacturing standards in the EU for active substances are those of the ‘International Conference for Harmonization’ – ICH Q7.

Council in this context is organizing an “Interactive Meeting with European Commission” on 13th September 2012 at 6:00 pm, followed by Dinner at Hotel Taj Deccan, Hyderabad.

Mr. Stefan Fuehring, Policy Officer, looking after quality, safety and efficacy of medicinal products in the Directorate General of Health and Consumers, European Commission is visiting Hyderabad and will be making presentation/interacting on,

·         Quality of Medicines and Technology Solutions on Falsified Medicines
·         New rules on importing APIs into the European Union

In view of the above, we request all our member companies to utilize the presence of Mr. Stefan and have the required clarifications for exporting APIs to EU. To defray the expenses, we are charging a nominal fee of Rs.500 towards Registration Fee, payable in the name of Pharmaceuticals Export Promotion Council of India, Hyderabad/Mumbai.

Members interested in attending the Interactive Meeting are requested to confirm their participation by email at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or by fax at 040-23735464.

With regards,  

Dr.P.V.Appaji
Director General

101, Aditya Trade Centre, Ameerpet, Hyderbad-500038
Tel: 040-23735462/66, Fax: 040-23735464
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Website: www.pharmexcil.com

 
 
Site visited Free Web Counters  
  (From: 21-06-2012)  
Copyright © 2009 Pharmexcil. All rights reserved.
Powered by: iBongo Inc